Home Stock

Stock Research: Ebos

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Ebos

NZC:EBO NZEBOE0001S6
53
  • Value
    97
  • Growth
    5
  • Safety
    Safety
    18
  • Combined
    22
  • Sentiment
    94
  • 360° View
    360° View
    53
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

EBOS Group Limited is a marketer, wholesaler, and distributor of healthcare, medical, and pharmaceutical products, and animal care brands. It operates in the Healthcare and Animal Care industries and includes brands such as Symbion, ProPharma, and TerryWhite Chemmart. It operates in Australia and New Zealand. In the last fiscal year, the company had a market cap of $4,833 million, profits of $1,089 million, revenue of $8,793 million, and 5200 employees.

more

ANALYSIS: With an Obermatt 360° View of 53 (better than 53% compared with alternatives), overall professional sentiment and financial characteristics for the stock Ebos are above average. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for Ebos. The consolidated Value Rank has an attractive rank of 97, which means that the share price of Ebos is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 97% of alternative stocks in the same industry. The consolidated Sentiment Rank has a good rank of 94, which means that professional investors are more optimistic about the stock than for 94% of alternative investment opportunities. But the consolidated Growth Rank has a low rank of 5, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. The consolidated Safety Rank has a riskier rank of 18, meaning the company has a riskier financing structure than 82 comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Strongest Rank Stock Returns
Weakest Rank Value
Country Australia
Industry Health Care Distributors
Size Large
Website ebosgroup.com
Index
ASX 200
ASX 300
NZSX 50
Ebos stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
97 11 16 15
Growth
5 43 3 91
Safety
Safety
18 39 55 55
Sentiment
94 65 62 82
360° View
360° View
53 22 12 77
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
72 53 34 49
Opinions Change
83 68 21 50
Pro Holdings
n/a 27 82 60
Market Pulse
38 81 76 85
Sentiment
94 65 62 82
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
97 11 16 15
Growth
5 43 3 91
Safety Safety
18 39 55 55
Combined
22 12 6 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
92 51 66 61
Price vs. Earnings (P/E)
79 17 23 16
Price vs. Book (P/B)
53 14 17 23
Dividend Yield
97 40 48 36
Value
97 11 16 15
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
7 49 1 61
Profit Growth
63 20 49 31
Capital Growth
18 22 7 87
Stock Returns
3 71 15 87
Growth
5 43 3 91
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
24 37 48 52
Refinancing
53 10 24 28
Liquidity
25 68 69 62
Safety Safety
18 39 55 55

Similar Stocks

Discover high‑ranked alternatives to Ebos and broaden your portfolio horizons.

Shionogi

TYO:4507
Country: Japan
Industry: Pharmaceuticals
Size: X-Large
Full Stock Analysis

Alfresa Holdings

TYO:2784
Country: Japan
Industry: Health Care Distributors
Size: X-Large
Full Stock Analysis

Kyowa Hakko Kirin

TYO:4151
Country: Japan
Industry: Pharmaceuticals
Size: X-Large
Full Stock Analysis

Astellas Pharma

TYO:4503
Country: Japan
Industry: Pharmaceuticals
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

With good value and positive sentiment, but low growth and risky financing, this combination is generally dangerous as debt requires growth to sustain it. Only investors with a strong belief in future growth potential and a high-risk tolerance should consider this stock.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews